All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

37

Reset

37 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • HSK44459Phase 39 trials

    Haisco Pharmaceutical Group Co., Ltd. · Psoriasis, Idiopathic Pulmonary Fibrosis (IPF), Progressive Pulmonary Fibrosis

  • Inhaled TreprostinilLIQ861 Inhaled Treprostinil, Inhaled prostacyclinPhase 35 trials

    United Therapeutics · Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Progressive Pulmonary Fibrosis

  • BMS-986278AdmilparantPhase 33 trials

    Bristol Myers Squibb · Pulmonary Fibrosis, Progressive Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis

  • HEC585Phase 33 trials

    Sunshine Lake Pharma Co., Ltd. · Progressive Fibrosing Interstitial Lung Disease (PF-ILD) / Progressive Pulmonary Fibrosis (PPF), Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF)

  • BI 1015550Phase 32 trials

    Boehringer Ingelheim · Lung Diseases, Interstitial, Idiopathic Pulmonary Fibrosis

  • DeupirfenidonePhase 32 trials

    PureTech · Idiopathic Pulmonary Fibrosis (IPF), Idiopathic Pulmonary Fibrosis

  • INS018_055Phase 32 trials

    InSilico Medicine Hong Kong Limited · Idiopathic Pulmonary Fibrosis (IPF), Idiopathic Pulmonary Fibrosis

  • REGEND001Phase 32 trials

    Regend Therapeutics · COPD (Chronic Obstructive Pulmonary Disease), Idiopathic Pulmonary Fibrosis

  • TDI01Phase 32 trials

    Beijing Tide Pharmaceutical Co., Ltd · GVHD, Chronic, Idiopathic Pulmonary Fibrosis (IPF)

  • AK3280Phase 31 trial

    Shanghai Ark Biopharmaceutical Co., Ltd. · Idiopathic Pulmonary Fibrosis (IPF)

  • SC1011Phase 31 trial

    Guangzhou JOYO Pharma Co., Ltd · Idiopathic Pulmonary Fibrosis

  • HB0056Phase 22 trials

    Shanghai Huaota Biopharmaceutical Co., Ltd. · Asthma, Idiopathic Pulmonary Fibrosis (IPF)

  • IfetrobanPhase 22 trials

    Cumberland Pharmaceuticals · Scleroderma, Diffuse, Scleroderma, Systemic, Scleroderma, Limited

  • TTI-101Phase 22 trials

    Tvardi Therapeutics, Incorporated · Hepatocellular Carcinoma, Idiopathic Pulmonary Fibrosis

  • ABBV-142Phase 21 trial

    AbbVie · Idiopathic Pulmonary Fibrosis

  • AGMB-447Phase 21 trial

    Agomab Spain S.L.U. · Idiopathic Pulmonary Fibrosis (IPF)

  • AP02Phase 21 trial

    Avalyn Pharma Inc. · Idiopathic Pulmonary Fibrosis (IPF)

  • AZD8965Phase 21 trial

    AstraZeneca · Idiopathic Pulmonary Fibrosis (IPF)

  • BBT-877Phase 21 trial

    Bridge Biotherapeutics, Inc. · Idiopathic Pulmonary Fibrosis

  • BC006Phase 21 trial

    Dragonboat Biopharmaceutical Company Limited · Idiopathic Pulmonary Fibrosis (IPF)

  • BI 1819479Phase 21 trial

    Boehringer Ingelheim · Idiopathic Pulmonary Fibrosis

  • BI 3810477Phase 21 trial

    Boehringer Ingelheim · Idiopathic Pulmonary Fibrosis

  • BI 765423Phase 21 trial

    Boehringer Ingelheim · Idiopathic Pulmonary Fibrosis

  • CAL101Phase 21 trial

    Calluna Pharma AS · Idiopathic Pulmonary Fibrosis

  • CHF10067Phase 21 trial

    Chiesi Farmaceutici S.p.A. · Idiopathic Pulmonary Fibrosis

  • DWN12088DWN12088 XmgPhase 21 trial

    Daewoong Pharmaceutical Co. LTD. · Idiopathic Pulmonary Fibrosis

  • ENV-101taladegibPhase 21 trial

    Endeavor Biomedicines, Inc. · Idiopathic Pulmonary Fibrosis, Progressive Fibrosing Interstitial Lung Disease

  • HSK50042Phase 21 trial

    Haisco Pharmaceutical Group Co., Ltd. · Idiopathic Pulmonary Fibrosis (IPF)

  • LTI-03Phase 21 trial

    Rein Therapeutics · Idiopathic Pulmonary Fibrosis (IPF)

  • MTX-463Phase 21 trial

    Mediar Therapeutics · Idiopathic Pulmonary Fibrosis

  • ND-003Phase 21 trial

    Shenzhen NewDEL Biotech, Co., Ltd · Idiopathic Pulmonary Fibrosis (IPF)

  • ORJ-001Phase 21 trial

    Oorja Bio, Inc. · Idiopathic Pulmonary Fibrosis

  • PIPE-791Phase 21 trial

    Contineum Therapeutics · Idiopathic Pulmonary Fibrosis

  • SB17170Phase 21 trial

    SPARK Biopharma · IPF, Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF)

  • SV001Phase 21 trial

    Shanghai Synvida Biotechnology Co.,Ltd. · Idiopathic Pulmonary Fibrosis(IPF)

  • SYH2059Phase 21 trial

    InnovStone Therapeutics Limited · Idiopathic Pulmonary Fibrosis

  • SYH9061Phase 21 trial

    CSPC-NBP Pharmaceutical Co., Ltd. · Idiopathic Pulmonary Fibrosis

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.